Skip to main content

Else Nutrition Holdings Inc(BABY-T)
TSX

Today's Change
Real-Time Last Update
Day Low0.0800
Day High0.1000
Open:0.1000
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

TOP STORIES: Else Nutrition Holdings Inc

Select a category then submit the form to load news
Baystreet
Stocks in play: Else Nutrition Holdings Inc.
Newswire.ca
Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards
Baystreet
Stocks in play: Else Nutrition Holdings Inc.
PR Newswire
Else Nutrition Surpasses One Million Cans Sold Since Launch
Newswire.ca
Else Nutrition Announces Results from Annual General Meeting of Shareholders
Baystreet
Stocks in play: Else Nutrition Holdings Inc.
Newswire.ca
Else Nutrition Plans Canadian Market Relaunch in 2026
Newswire.ca
Else Nutrition Announces Appointment of Natie Zilberberg as Chief Financial Officer
Baystreet
Stocks in play: Else Nutrition Holdings Inc.
Newswire.ca
ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
ACCESS Newswire
Else Nutrition CEO to Present at Investor Summit Virtual on December 9, 2025
Baystreet
Stocks in play: Else Nutrition Holdings Inc.
Newswire.ca
Else Nutrition Secures Five-Year Renewal of Israel's Largest Health Fund Tender for Baby Feeding Solutions
Baystreet
Stocks in play: Else Nutrition Holdings Inc.
Newswire.ca
ELSE ANNOUNCES INVESTMENT FOR GROSS PROCEEDS OF UP TO US$1,280,000
Newswire.ca
Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call
Newswire.ca
Else Nutrition Schedules 2025 Third Quarter Business Update Conference Call
Newswire.ca
ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION
Baystreet
Stocks in play: ELSE NUTRITION HOLDINGS INC.
Newswire.ca
Else Nutrition Schedules 2025 Second Quarter Business Update Conference Call
Newswire.ca
Else Nutrition Reports 2025 First Quarter Financial Results and Provides Business Update
Newswire.ca
Else Nutrition Schedules 2025 First Quarter Business Update Conference Call
Newswire.ca
ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Baystreet
Stocks in play: Else Nutrition Holdings Inc.
Newswire.ca
Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation
Newswire.ca
ELSE NUTRITION ANNOUNCES DELAY IN FILING FINANCIAL STATEMENTS AND EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Newswire.ca
Else Nutrition Applauds U.S. Government's Historic Shift in Infant Formula Rules, Unlocking Path to Commercialize the World's First Whole-Food, Dairy-Free Infant Formula
Newswire.ca
Else Nutrition Reports 2024 Fiscal Year Financial Results and Provides Business Update
Baystreet
Stocks in play: Else Nutrition Holdings Inc.
Newswire.ca
Else Nutrition CEO Highlights Urgent Need for Infant Formula Alternatives in The Washington Times Op-Ed
AI-generated - The Globe and Mail
Else Nutrition Holdings: Top 10 Undervalued Consumer Defensive Sector Stocks on TSX (BABY)
AllPennyStocks.com
Micro Cap Surges on Major Retail Breakthrough
Micro Cap Surges on Major Retail Breakthrough

Profile

Else Nutrition Holdings Inc is a food and nutrition company in the international expansion stage focused on developing clean, and Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.